Related Experiment Video
Updated: Mar 3, 2026

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS
Published on: January 23, 2026
Next Generation Antineoplastic Agents: A Review on Structurally Modified Vinblastine (VBL) Analogues
Ashanul Haque1, Md Ataur Rahman2, Md Serajul Haque Faizi1
1Department of Chemistry, Sultan Qaboos University, P.O. Box 36, Al-Khod 123, Muscat, Oman.
Vinblastine analogues show promise in cancer chemotherapy, with modifications leading to enhanced anticancer activity. Research explores new formulations and modifications to the core structure for next-generation antineoplastic agents.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Cancer remains a significant global health challenge despite medical advancements.
- Vinblastine, a key alkaloid from *Catharanthus roseus*, is a clinically used antineoplastic agent.
- Structural modifications of vinblastine aim to enhance efficacy and reduce side effects.
Purpose of the Study:
- To review recently developed vinblastine analogues and their impact on biological activity.
- To analyze the role of structural modifications in anticancer efficacy.
- To discuss novel vinblastine-based formulations in clinical trials.
Main Methods:
- Comprehensive literature search of computational and experimental studies on vinblastine analogues.
- Analysis of modifications to both catharanthine and vindoline units.
- Evaluation of functional group impact on anticancer properties.
Main Results:
- Identified key sites on the vinblastine core for modification to improve anticancer activity.
- Discussed mechanisms of action for vinblastine and its analogues.
- Highlighted new formulations undergoing clinical trials for various cancers.
Conclusions:
- Vinblastine is crucial in cancer chemotherapy.
- Novel analogues exhibit potent activity, with some reaching the picomolar range.
- Modification of both peripheral and core structures can yield next-generation antineoplastic agents.
More Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Related Concept Videos
Drugs that Destabilize Microtubules
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...